Abstract
Activation of the classical complement (C) system involves conversion of C1 to its active state with subsequent cleavage of C4 and -d C2 so as to form the classical C3 convertase, C42 (a bar indicates the activated form of a protein), which sequentially cleaves C3 and C5 to initiate the cytolytic event associated with the complete reaction. An alternative, pr properdin-dependent, pathway to complement activation generates a C3 convertase, C3B, that is formed by cleavage of B with D in the presence of a C3b, the major cleavage fragment of C3. C3b is capable of binding activated properidin (P) with resultant stabilization of C3B, which otherwise rapidly decays by loss of B activity. Initial cleavage of C3, a prerequisite for formation of C3B, is demonstrated to occur through the interaction of native C3 and B in the presence of either D or P alone, or together. The effect of P on the interaction of D, B, and C3 is attributed to stabilization of C3B as has been shown for C3B. Larger amounts of P and B with C3 in the absence of D form a C3 convertase that is designated (P)C3B to indicate that demonstrable cleavage of B does not occur although the active site is available. The generation of this initial convertase, as assessed by C3 inactivation, is dose-related to P and B inputs. The presence of both P and D greatly augments initial cleavage of C3 with D fully uncovering the active site of B and P stabilizing that site.
MeSH Terms
Complement C3/metabolism
Complement System Proteins/metabolism
Humans
Immunoelectrophoresis
Precipitin Tests
Properdin/metabolism
Chemicals
Complement C3
Properdin
Complement System Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Fearon D T
Austen K F
References (22)
22 references, click to expand
-
The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system.
Z Immun exp ther. 1959 Oct-Nov;118:349-57
PMID: 13801696
-
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
J Exp Med. 1965 Aug 1;122:277-98
PMID: 14316946
-
C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.
J Exp Med. 1965 May 1;121:819-33
PMID: 14280442
-
Chromatographic resolution of the first component of human complement into three activities.
J Exp Med. 1963 Jun 1;117:983-1008
PMID: 13929797
-
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.
Science. 1954 Aug 20;120(3112):279-85
PMID: 13186838
-
Protein measurement with the Folin phenol reagent.
J Biol Chem. 1951 Nov;193(1):265-75
PMID: 14907713
-
The membrane attack mechanism of complement. Verification of a stable C5-9 complex in free solution.
J Exp Med. 1973 Aug 1;138(2):438-51
PMID: 4719679
-
Glomerular and dermal depostion of properdin in systemic lupus erythematosus.
N Engl J Med. 1972 Oct 5;287(14):681-5
PMID: 4115613
-
The C3-activator system: an alternate pathway of complement activation.
J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s
PMID: 4105810
-
C3 proactivator convertase and its mode of action.
J Exp Med. 1972 Apr 1;135(4):1003-8
PMID: 4111773
-
A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component.
J Immunol. 1967 Dec;99(6):1162-72
PMID: 4168662
-
Properties of highly purified human properdin.
J Immunol. 1968 Jan;100(1):142-58
PMID: 4169693
-
Some physical-chemical properties of chicken gamma-globulins and their pepsin and papain digestion products.
Immunochemistry. 1966 Jan;3(1):11-20
PMID: 4161754
-
Properdin factor D. II. Activation to D by properdin.
J Exp Med. 1974 Aug 1;140(2):426-36
PMID: 4211020
-
Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.
J Exp Med. 1973 Dec 1;138(6):1305-13
PMID: 4202731
-
Properdin factor D: characterization of its active site and isolation of the precursor form.
J Exp Med. 1974 Feb 1;139(2):355-66
PMID: 4855753
-
The role of properdin in the alternate pathway of complement activation.
J Exp Med. 1974 Jan 1;139(1):44-57
PMID: 4808709
-
Formation and function of a complex of the C3 proactivator with a protein from cobra venom.
J Exp Med. 1973 Feb 1;137(2):451-60
PMID: 4734404
-
The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum.
J Exp Med. 1973 Feb 1;137(2):424-37
PMID: 4734403
-
Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).
J Immunol. 1973 Jan;110(1):128-38
PMID: 4734384
-
C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
J Immunol. 1969 Mar;102(3):533-43
PMID: 5813010
-
Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
J Exp Med. 1967 Feb 1;125(2):359-80
PMID: 6019133